Impaired proliferation of CD8 T cells after CY treatment.
2013-02-21T04:43:21Z (GMT) by
<p>(A) Draining lymph node cells from tumor-bearing mice treated with saline, CY or gemcitabine (GEM) at day 10 post inoculation were analyzed for Ki-67 expression three days later. Cells shown were gated such that CD8<sup>neg</sup> cells are CD4 T cells. Data shown in lower panel are mean±SEM (<i>n</i> = 3) from one experiment. ** P<0.01 when PBS is compared with CY (unpaired t test). (B) Adoptively transferred transgenic CD8 T cells fail to proliferate in CY-treated mice. CFSE-labeled HA-specific clone 4 cells were transferred into tumor bearing mice two days before PBS or CY injection and were harvested 7 days later and stained for CD8 expression. Cells shown are gated as CD8<sup>+</sup>. Data shown in lower panel are mean±SEM (<i>n</i> = 3) from one experiment. * P<0.05 when PBS is compared with CY (unpaired t test). (C) HA-specific MHC class I pentamer staining in untreated and CY-treated tumor-bearing mice. Data shown are frequencies of pentamer+ CD8 T cells per total CD8 T cells in tumor-draining lymph nodes at day 10 post CY injection. <i>ns</i> = not significant (P = 0.06, unpaired t test). (D) CD43 (clone 1B11) expression on pentamer<sup>+</sup> CD8 T cells in tumor-draining lymph nodes. Cells shown are gated on CD8<sup>+</sup> cells. Representative plots are shown.</p>